2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

January 2017 | 350 pages | ID: 2701B37F28DEN
Venture Planning Group

Abstracts

About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report:

Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

Reviews features and operating characteristics of major analyzers used for STD testing;

Profiles key suppliers and potential market entrants developing innovative technologies and products; and

Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data files was conducted. Contains 350 pages and 90 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. Chancroid
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2. Chlamydia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  3. Gonorrhea
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. Herpes Simplex Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
      Human Herpes Virus-6 (HHV-6)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. Papillomavirus (HPV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. Syphilis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Testing Market Diagnostics Sales by Major Supplier
France PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
France Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
France Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
France Syphilis Testing Market Diagnostics Sales by Major Supplier
Germany Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Germany Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Herpes Testing Market Diagnostics Sales by Major Supplier
Germany PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Italy Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Italy PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Japan Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Japan Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Herpes Testing Market Diagnostics Sales by Major Supplier
Japan PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Syphilis Testing Market Diagnostics Sales by Major Supplier
Spain Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
Spain Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Herpes Testing Market Diagnostics Sales by Major Supplier
Spain PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Syphilis Testing Market Diagnostics Sales by Major Supplier
U.K. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Herpes Testing Market Diagnostics Sales by Major Supplier
U.K. PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier